Skip to main content

Table 3 The associations between adiponectin (ADPN) and lung function in percent of predicted adjusting for different covariates one by one

From: The association between circulating adiponectin levels, lung function and adiposity in subjects from the general population; data from the Akershus Sleep Apnea Project

 

Unstandardized beta (95% CI) ADPN (per SD)

FEV1% of predicted

p

FVC % of predicted

p

Unadjusted

1.012 (− 0.365, 2.388)

0.149

3.414 (2.047, 4.781)

< 0.001

Adjusted for

Weight (per 5 kg)

0.060 (− 1.445, 1.566)

0.937

2.166 (0.681, 3.651)

0.004

BMI

0.303 (− 1.139, 1.744)

0.680

2.658 (1.229, 4.087)

< 0.001

WHR

− 1.213 (− 2.771, 0.345)

0.127

0.425 (− 1.085,1.935)

0.581

Current smoking

1.393 (0.048, 2.739)

0.042

3.556 (2.172, 4.941)

< 0.001

Previous smoking

1.380 (0.017, 2.742)

0.047

3.529 (2.141, 4.917)

< 0.001

Metabolic syndrome

0.353 (−1.078, 1.785)

0.628

2.610 (1.195, 4.025)

< 0.001

OSA

1.090 (−0.299, 2.480)

0.124

3.282 (1.90, 4.664)

< 0.001

CRP(per SD)

0.834 (−0.537, 2.206)

0.232

3.262 (1.897, 4.626)

< 0.001

  1. FEV 1 forced expiratory volume during 1st second, FVC forced vital capacity, CI confidence interval, ADPN adiponectin, BMI body mass index, WHR waist-hip ratio, OSA obstructive sleep apnoea, CRP c-reactive protein